Early mortality in systemic vasculitis: relative contribution of therapy-associated adverse events and active vasculitis

被引：0
|
作者：
Little, Mark [1 ]
Nightingale, Peter [2 ]
Hauser, Thomas [3 ]
de Groot, Kerstin [4 ]
Savage, Caroline [1 ]
Jayne, David [5 ]
Harper, Lorraine [1 ]
机构：
[1] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England
[2] Univ Hosp Birmingham NHS Fdn Trust, Wellcome Trust CRF, Birmingham, W Midlands, England
[3] Univ Zurich Hosp, Div Clin Immunol, CH-8091 Zurich, Switzerland
[4] Klinikum Offenbach, Dept Med, Offenbach, Germany
[5] Addenbrookes Hosp, Cambridge, England
来源：
APMIS | 2009年 / 117卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [21] Simultaneous assessment of targeted anticancer therapy-associated mucocutaneous adverse events.
    Boers-Doets, Christine Bettine
    Gelderblom, Hans
    Epstein, Joel Brian
    Lacouture, Mario E.
    Kaptein, Ad A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Plasmapheresis rescue therapy in progressive ANCA-associated systemic vasculitis
    de Joode, A. A. E.
    Sanders, J. S. F.
    Stegeman, C. A.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 53 - 54
  • [23] Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy-Associated Adverse Events
    Witjes, J. Alfred
    Palou, Joan
    Soloway, Mark
    Lamm, Donald
    Brausi, Maurizio
    Spermon, J. Roan
    Persad, Raj
    Buckley, Roger
    Akaza, Hideyuki
    Colombel, Marc
    Boehle, Andreas
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (10) : 667 - 674
  • [24] MORTALITY AND EARLY SEVERE INFECTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Waki, D.
    Nishimura, K.
    Kadoba, K.
    Mukoyama, H.
    Saito, R.
    Yokota, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 772 - 773
  • [25] GLUCOCORTICOID EXPOSURE AND LINK TO SERIOUS ADVERSE EVENTS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Spearpoint, Philip
    Sammon, Cormac
    Ramirez, de Antonio
    Serna, Arellano
    Rutherford, Peter
    [J]. RHEUMATOLOGY, 2020, 59
  • [26] Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study
    Gialouri, Chrysoula G.
    Chalkia, Aglaia
    Koutsianas, Christos
    Chavatza, Katerina
    Argyriou, Evangelia
    Panagiotopoulos, Alexandros
    Karamanakos, Anastasios
    Dimouli, Aikaterini
    Tsalapaki, Christina
    Thomas, Konstantinos
    Orfanos, Philippos
    Lagiou, Pagona
    Katsikas, George
    Boki, Kyriaki
    Boumpas, Dimitrios
    Petras, Dimitrios
    Vassilopoulos, Dimitrios
    [J]. RHEUMATOLOGY, 2024,
  • [27] Rituximab Therapy for Systemic Vasculitis Associated with Rheumatoid Arthritis in the AutoImmunity and Rituximab Registry
    Puechal, Xavier
    Gottenberg, Jacques-Eric
    Berthelot, Jean-Marie
    Gossec, Laure
    Meyer, Olivier
    Morel, Jacques
    Wendling, Daniel
    De Bandt, Michel
    Houvenagel, Eric
    Jamard, Benedicte
    Lequerre, Thierry
    Morel, Gauthier
    Richette, Pascal
    Sellam, Jeremie
    Guillevin, Loic
    Mariette, Xavier
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S929 - S929
  • [28] Outcome of renal replacement therapy in ANCA-associated systemic vasculitis.
    Allen, A
    Pusey, C
    Gaskin, G
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (06) : 2568 - 2568
  • [29] Complications of long-term therapy for ANCA-associated systemic vasculitis
    Nadezhda Wall
    Lorraine Harper
    [J]. Nature Reviews Nephrology, 2012, 8 : 523 - 532
  • [30] Complications of long-term therapy for ANCA-associated systemic vasculitis
    Wall, Nadezhda
    Harper, Lorraine
    [J]. NATURE REVIEWS NEPHROLOGY, 2012, 8 (09) : 523 - 532
12345